Functional characterisation of cell-type specific regulatory networks is key to establish a 24 causal link between genetic variation and phenotype. The osteoclast offers a unique model 25 for interrogating the contribution of co-regulated genes to in vivo phenotype as its 26 multinucleation and resorption activities determine quantifiable skeletal traits. Here we took 27 advantage of a trans-regulated gene network (MMnet, macrophage multinucleation network) 28 which we found to be significantly enriched for GWAS variants associated with bone-related 29 phenotypes. We found that the network hub gene Bcat1 and seven other co-regulated 30
Introduction

45
The large number of common genetic variants associated with prevalent complex 46 diseases suggests that disease pathogenesis involves perturbations to intricate gene networks (Furlong, 2013) . The recently proposed omnigenic model of complex traits 48 highlights the importance of trans-regulated networks in understanding causative disease 49 pathways (Boyle et al., 2017; Liu et al., 2019) . One way of mapping these regulatory 50 networks is to identify the genetic control points of gene co-expression networks in a cell 51 type relevant to the disease of interest. In this way, expression quantitative trait loci (eQTL) 52 studies have revealed regions of the genome that harbour sequence variants affecting the 53 mRNA expression levels of one or more genes (Albert and Kruglyak, 2015) . These 54 approaches identified trans-eQTLs, which regulate gene expression that are often observed 55 in clusters, also known as trans-eQTL hotspots ( Bone-resorbing multinucleated osteoclasts are derived from the monocyte-macrophage 65 lineage (Pereira et al., 2018) . They display high metabolic activity (Indo et al., 2013) and 66 regulate bone mass, structure and strength. Abnormal osteoclastic bone resorption is a 67 major underlying cause of both low and high bone mass disorders including osteoporosis 68 (Manolagas, 2010) , and osteopetrosis (Sobacchi et al., 2013) , and an important contributor 69 to the pathogenesis of Paget's disease (Galson and Roodman, 2014) , adolescent idiopathic 70 scoliosis (AIS) (Liu et al., 2018) , and inflammatory diseases that affect the skeleton such as 71 rheumatoid arthritis, ankylosing spondylitis and periodontitis (DiCarlo and Kahn, 2011; 72 McInnes and Schett, 2011). Recent genome-wide association studies (GWAS) have 73 identified hundreds of polymorphic loci associated with bone diseases in humans, including 74 many that contain osteoclast-related genes ( However, only a few causal genes have been implicated in disease onset and progression, 77 suggesting that activities of complex interacting gene networks play a crucial role in 78 establishing and optimising bone mass and strength and in the pathogenesis of skeletal 79 disease (Al-Barghouthi and . 80
We previously developed a rapid-throughput skeletal phenotyping pipeline that combines 81 both structural and functional parameters (Bassett et al., 2012a; Freudenthal et al., 2016) . 82
We first applied this multi-parameter phenotyping pipeline to analyse 100 knockout (KO) 83 mice and reported 9 new genetic determinants of bone mineralisation, structure and strength 84 (Bassett et al., 2012a) . We then extended our studies to over 500 KO mouse lines and 85 integrated this large-scale phenotype resource with over 1000 conditionally independent 86 SNPs at over 500 loci that significantly associate with bone mineral density (BMD) and 87 fracture in GWAS to provide functional evidence of causation for candidate genes (Kemp et studies provide systems-level platforms for gene identification in skeletal disorders. Robust 91 systems genetics approaches also incorporate functional assays in a context-dependent cell 92 type such that the effect of genome variation can be investigated to identify cell-specific 93 mechanisms of disease. The osteoclast has an important advantage as its multinucleation 94 capability correlates with its resorptive activity as well as with quantitative in vivo traits such 95 as bone mass, structure and strength (Pereira et al., 2018) . Thus, we hypothesise that 96 osteoclast gene regulatory networks play a key role to establish and maintain optimal bone 97 structure and strength, and are perturbed in skeletal disease. 98
We previously investigated the genetic determinants of macrophage multinucleation, using 99 the inbred Wistar Kyoto (WKY) rat strain that displays spontaneous macrophage fusion 100 (Kang et al., 2014 Femurs and caudal vertebrae 6 and 7 from 16 week-old mice and 14 week-old rats were 144 fixed in 70% ethanol. Soft tissue was removed and digital X-ray images were recorded at 10 145 µm pixel resolution using a Faxitron MX20 variable kV point projection X-ray source and 146 digital image system (Qados, Cross Technologies plc, UK) operating at 26 kV and 5x 147 magnification. Bone mineral content (BMC) was determined relative to steel, aluminium and 148 polyester standards as described (Bassett et al., 2012b) . Images were calibrated with a 149 digital micrometre and bone and vertebra length was determined (Bassett et al., 2012a; 150 Bassett et al., 2012b) . 151
Micro-computerised tomography (micro-CT) 152
Mouse and rat femurs were analysed by micro-CT (Scanco uCT50, 70 kV, 200 μA, 0.5-mm 153 aluminium filter) as described (Bassett et al., 2012a) . Measurements included cortical bone 154 parameters (cortical thickness (Ct.Th), cortical bone mineral density (Ct.BMD), internal 155 diameter (Int.Dia) and bone area (Ct.Ar) at 10μm 3 voxel resolution in a 1.5mm 2 region 156 centred on the mid-shaft region 56% of the way along the length of the femur distal to the 157 femoral head, and trabecular parameters (bone volume (BV/TV), trabecular number (Tb.N), 158 thickness (Tb.Th), spacing (Tb.Sp), structure model index (SMI) and trabecular BMD 159 (Tb.BMD)) at 5μm 3 voxel resolution in a 1mm 2 region beginning 100μm proximal to the distal 160 growth plate. Parameters were determined using Scanco analysis software. 161
Destructive 3-point bend testing 162
Destructive 3-point bend tests were performed on femurs and compression tests on caudal 163 vertebrae 6 and 7 using an Instron 5543 load frame and load cell (100N for mouse femurs 164 and 500N for mouse caudal vertebrae and rat bones) (Instron Limited, High Wycombe, 165
Buckinghamshire, UK) as described (Bassett et al., 2012a) . Bones were positioned 166 horizontally on custom supports and load was applied perpendicular to the mid-diaphysis 167 with a constant rate of displacement of 0.03 mm/s until fracture. Vertebrae were bonded in 168 vertical alignment to a custom anvil support using cyanoacrylate glue and load was applied 169 vertically at a constant rate of displacement of 0.03 mm/s and a sample rate of 20 Hz. Yield 170 load, maximum load, fracture load, stiffness and toughness (Energy dissipated prior to 171 fracture) were determined from femur load displacement curves and yield load, maximum 172 load and stiffness from caudal vertebrae load displacement curves.. 173
Osteoclast histomorphometry 174
Osteoclast numbers were determined according to the American Society for Bone and 175
Mineral Research system (Dempster et al., 2013) in paraffin sections from decalcified mouse 176 femurs stained for tartrate resistant acid phosphatase (TRAP) activity, counterstained with 177 aniline blue and imaged using a Leica DM LB2 microscope and DFC320 digital camera 178 (Bassett et al., 2014) . A montage of nine overlapping fields covering an area of 1mm 2 179 located 0.2mm below the growth plate was constructed for each bone. BV/TV was 180 measured, and osteoclast numbers and surface were determined in trabecular bone 181 normalised to total bone surface (Bassett et al., 2014) . 182
Cell culture, transfection and assessment of cell multinucleation 183
Human monocyte-derived macrophages were separated from healthy donor buffy coats by 184 centrifugation through a Histopaque 1077 (Sigma) gradient and adhesion purification. 185
Following Histopaque separation, peripheral blood mononuclear cells were re-suspended in 186 RPMI (Life Technologies) and monocytes purified by adherence for 1 h at 37 °C, 5% CO 2 in 187 twelve-well plates. The monolayer was washed 3 times with HBSS to remove non-adherent 188 
In vitro resorption 208
In vitro resorption activity of human osteoclasts was measured on Osteo Assay Surface 96 209 well plates (Corning). siRNA transfected cells were incubated with cell dissociation buffer 210 (Sigma) and 10 5 cells/well were seeded in Osteo Assay Surface Plates. After 2 days of 211 culture with 20 ng/ml M-CSF and 20 ng/ml recombinant human RANKL (PeproTech, UK), the 212 wells were rinsed twice with PBS and incubated with 10% bleach solution for 30 min at room 213 temperature. The wells were then washed twice with PBS and allowed to dry at room 214 temperature. Individual resorption pits were imaged by light microscopy. Images were 215 inverted and processed using Photoshop to yield high-contrast images and show the 216 resorbed areas in black against a white background. Binary images of each individual well 217 were then subjected to automated analysis (ImageJ), using constant "threshold" and 218 "minimum particle" levels, to determine the number and surface area of resorbed pits. 219
Statistical analysis 220
Data are presented as mean ± standard deviations (SD) and analysed using GraphPad 221
Prism software (version 7.02; GraphPad). Normally distributed data were analysed by 2 222 tailed Student's t test. Relationships between micro-CT parameters and in vitro 223 osteoclastogenesis were determined by Pearson correlation. Frequency distributions of bone 224 mineral densities obtained by x-ray microradiography were compared using the Smirnov test. Differences in percentage of control following si-RNA knockdown in primary 226 osteoclasts were tested for significance using a one-sample-t test. 227 IMPC mutant lines were compared to C57BL6/J strain-specific reference ranges that have 228 been established for all parameters using 16 week-old female wild-type mice (n=320) 229 obtained from control cohorts. Strains in which a structural or functional parameter was ±2.0 230 SD from the C57BL6/J reference mean were considered as outliers. 231
The hypergeometric test was used to determine whether the MMnet network (n=190 rat 232 genes, of which 178 genes had a unique human orthologue) was enriched for genes with a 233 GWAS signal (P<10 -6 ) for traits related to bone and height (Table 1) 
in the NHGRI-EBI 234
Catalog of published GWAS (https://www.ebi.ac.uk/gwas/). Over-representation of GWAS 235 gene signals in MMnet was assessed in comparison with the whole set of eQTLs (n=1,527 236 genes, of which 1,448 genes had a unique human orthologue) that were previously mapped 237 in multinucleating macrophages (Kang et al., 2014) . Biomart was used to map rat genes to 238 the human orthologues (one-to-one orthology) using Ensembl rel. 98. 239
Results
240
MMnet regulates adult bone homeostasis via control of osteoclast multinucleation 241
MMnet is a co-expression network comprising 190 osteoclast-enriched eQTLs that are 242 regulated in trans by Trem2 (Kang et al., 2014) . It was generated by using primary 243 macrophages from a heterogenous rat population derived from experimental crossing of 244 that, compared to LEW rats, WKY rats have decreased bone length accompanied by low 250 bone mineral content (BMC), decreased trabecular bone volume (BV/TV) and thickness 251 (Tb.Th), together with reduced cortical bone thickness (Ct.Th) and mineral density (BMD). 252
These abnormalities resulted in markedly decreased bone strength ( Figure S1 ). Overall, 253 these data indicate that spontaneous macrophage and osteoclast multinucleation in WKY 254 rats is associated with low bone mass, mineralisation and strength. Thus, these findings 255 suggest that MMnet regulates adult bone homeostasis via its action in osteoclasts to control 256 multinucleation. 257
MMnet genes are enriched in human skeletal GWAS 258
To investigate further, we first determined whether MMnet eQTL genes are significantly 259 enriched for GWAS loci associated with bone disorders in humans. In comparison with the 260 background set of eQTLs (1,448 eQTLs that were previously mapped in multinucleating 261 macrophages (Kang et al., 2014) , MMnet was generally enriched for bone-related GWAS 262 loci (P=0.0085, hypergeometric test, Table 1 ) and more specifically for heel bone mineral 263 density associated GWAS variants (Table 1 and S1), which had the most significant 264 enrichment (20 loci, P=4.49x10 -3 , hypergeometric test, Table 1 ). Consistent with the 265 decreased bone length observed in WKY rats, MMnet was also significantly enriched for 266 body height variants (24 loci, P=1.86x10 -2 , hypergeometric test, Table 1 ). In addition to 267 enrichment for GWAS loci associated with skeletal traits, 9 MMnet genes have also been 268 implicated in the pathogenesis of rare monogenic skeletal disorders (CTSK, FAM20C, FLNA, 269 
mice) was performed using X-ray microradiography, micro-CT and biomechanical testing 300 ( Figure 2A ). Six of the 12 MMnet KO mouse lines exhibited abnormal skeletal phenotypes, 301
whereas Dot1l +/-, Egfr +/-, Eps15 -/-, Rnf125 -/-, Slc1a4 -/and Tgfb1i1 -/mice displayed no skeletal 302 abnormalities ( Figure 2B ). Igsf8 -/mice had decreased femur length (Table S2) Table S2 ). Biomechanical testing demonstrated decreased bone 306 strength in Atp8b2 +/-(decreased femur stiffness), Deptor -/-(decreased vertebral stiffness) 307
and Eml1 -/-(decreased vertebral stiffness) mice ( Figure 2E -F, Table S2 ). 308
Human MMnet orthologues regulate osteoclast multinucleation and resorption 309
To investigate whether the divergent skeletal phenotypes identified in MMnet knockout mice 310 correlate with osteoclast multinucleation and resorption in vitro, we determined the functional 311 consequences of siRNA-mediated knockdown of 11 human orthologues of these MMnet 312 genes in human osteoclasts (TGFB1I1 was not expressed). The MMnet gene DCSTAMP 313 was included as a positive control ( Figure 3A and S3A ). Knockdown of the 11 orthologous 314
MMnet genes did not affect cell viability and resulted in greater than 80% inhibition of MMnet 315 gene mRNA expression ( Figure S3B-C) . The functional consequences of in vitro siRNA 316 knockdown correlated with the skeletal consequences of gene deletion in vivo ( Figure 3B-D) . 317
Knockdown of DOTL1, EPS15 and RNF125 had no effect on osteoclast multinucleation or 318 resorption and the skeletal phenotype of the corresponding knockout mice was also 319 unaffected. Furthermore, knockdown of APPL2 inhibited osteoclast resorption and 320 knockdown of PIK3CB and ATP8B2 inhibited both multinucleation and resorption whilst the 321 corresponding knockout mice displayed increased bone mass. By contrast, knockdown of 322 DEPTOR resulted in a marked stimulation of both multinucleation and resorption, and 323 DEPTOR deficient mice had reduced bone mass and vertebral stiffness. Overall, the effects 324 of mRNA knockdown of MMnet genes on in vivo osteoclast multinucleation and resorption 325 were concordant and strongly correlated (R 2 = 0.76; P <0.001) ( Figure 3E ). Moreover, the 326 effect of knockdown of MMnet genes on osteoclast resorption was also strongly and 327 inversely correlated with trabecular bone mass (BV/TV) in knockout mice (R 2 = 0.65; P 328 <0.01) ( Figure 3F) . were used as a stepwise prioritisation filter (Table S3) Table S3 ). This prioritisation process identified five candidate MMnet genes (FGR, 349 LAT2, MYOF, FCGRT, and SLC40A1) ( Figure S4A-B) . To identify the most robust regulator 350 of osteoclast multinucleation we determined the consequences of siRNA-mediated 351 knockdown of these five genes in human osteoclasts. Knockdown of all five MMnet genes 352 resulted in greater than 80% inhibition of gene mRNA expression and greater than 40% 353 inhibition of multinucleation ( Figure S4C ). Most strikingly, knockdown of SLC40A1 (encoding 354 the mammalian iron transporter, ferroportin) resulted in more than 80% inhibition of 355 multinucleation, an effect comparable with that of the master regulator DCSTAMP (Figure  356 S4C-D). 357
Consequently, SLC40A1 was prioritised for further investigation and we generated a myeloid 358 lineage-specific knockout of Slc40a1 by crossing Slc40a1 flox/flox mice with LysM-cre mice. 359
Femurs from 16 week-old male and female mutant Slc40a1 ΔLysMCre and control Slc40a1 flox/flox 360 mice were analysed by X-ray-microradiography, microCT and 3-point bend testing (n=8 per 361 sex per genotype) (Figure 4 and Figure S5 ). Slc40a1 ΔLysMCre mice had greatly increased 362 bone mass characterised by increased BMC (Figure 4B-C in Slc40a1 ΔLysMCre mice ( Figure 4F ) and siRNA-mediated knockdown of SLC40A1 expression, 368 in human osteoclasts in vitro, inhibited osteoclast resorption by more than 85% ( Figure 4G we have used systems genetics approaches to demonstrate that a complex trans-eQTL 462 network (MMnet) facilitates homeostatic control of bone mass via its effects on osteoclast 463 fusion and function that are mediated in large part by the mTOR pathway. This 464 physiologically important network is conserved in rats, mice and humans and its 465 identification will lead the way to an understanding of the gene-gene interactions and 466 network-based therapeutic approaches that may be used in osteoclast-mediated 467 inflammatory disease or to prevent bone loss. 468 469 GWAS .Data from individual mice are shown as black dots and mean value by a red line (n = 2 or 6 720 per genotype). Parameters outside the WT reference rage are indicated by an asterisk *. 721 
